Latest News
HP Stock Plunges 10% on PC Shipment Slump, $3B Market Value Erased
HP shares tumbled 10.6% premarket as global PC shipments fell 16%, erasing $3 billion in market value, despite revenue growth of 12.5%.
CrowdStrike Stock Soars 9% Premarket on Record ARR, Raised Guidance
CrowdStrike (CRWD) jumped 9.3% premarket after record quarterly ARR and a $66M guidance raise. Market value increased by $18B.
Okta Shares Jump 20.9% on Strong Backlog, Raised Guidance
Okta's Q2 backlog beat by $75M and free cash flow surged 40%, sending shares up 20.9% and prompting a modest FY2027 guidance raise.
Fidelity's FBTC Sees $25.6M Inflow as Bitcoin Nears $80K
Fidelity's FBTC saw $25.6M in inflows on Aug 26, contributing to $232.2M in total spot Bitcoin ETF inflows. Bitcoin approached $80,000.
Salesforce Stock Jumps 11% on AI Revenue Surge, Raised Outlook
Salesforce shares jumped 11% premarket after strong Q2 earnings, with AI ARR reaching $3.9B and raised fiscal 2027 revenue guidance.
Nvidia Surges Premarket on Blowout Q2, Data Center Strength
Nvidia (NVDA) rose 7.4% premarket after reporting Q2 revenue of $96.22B, up 106% YoY, with data center sales surging 117%. Q3 guidance of $108B beat expectations.
Waymo's Munich Push Pressures Alphabet as Losses Widen
Alphabet shares slipped 1.2% as Waymo's Munich expansion plans collide with a 44.4% jump in Other Bets operating losses.
Real Home Values Slip Again as Inflation Outpaces Price Growth
U.S. home prices rose 1.5% year-over-year in June, but 3.5% inflation kept real values falling for a 13th month. Regional gaps widen as mortgage rates stay elevated.
Meta Shares Rise on $18B Child Safety Pact
Meta Platforms shares climbed 1.1% following an $18 billion child-safety settlement, boosting market value by $13.5 billion. The pact introduces new restrictions for young users.
D-Wave Stock Tumbles 9.5% on CFO Retirement; Market Cap Loses $679M
D-Wave Quantum shares dropped 9.5% following CFO retirement news, wiping out $679 million in market cap. Greg Golkov named acting CFO.
Revolution Medicines Rallies on RASONQUE Launch, Sales Forecasts
Revolution Medicines (RVMD) gains 2.3% premarket after RASONQUE's U.S. debut. RBC projects strong sales ramp, with Q3 at $28M and Q4 at $148M.